Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung × dupilumab × 1 year × Clear all

NCT05013450 2025-12-17

Dupilumab_Metastatic NSCLC

Phase 1/2 Active not recruiting

Carcinoma, Non-Small-Cell Lung